The CPTPP has been signed – no United States and “IP Lite”

The “CPTPP”, otherwise known as the Comprehensive and Progressive Agreement for Trans-Pacific Partnership is what remains of the “TPPA-11” (which was itself, what remained of the  Trans-Pacific Partnership (“TPP”) Free Trade Agreement following the withdrawal of the United States).  Earlier today (8 March 2018), in Santiago, Chile, the eleven remaining signatories put pen to paper

The curious case of IP and the “TPPA-11”

The “TPPA-11” is what remains of the Trans-Pacific Partnership (“TPP”) Free Trade Agreement following the withdrawal of the United States.  Because the TPP was never ratified prior to US withdrawal, some have termed it the “zombie” TPP.  Despite the absence of the US, there remains a strong resolve amongst the TPPA-11 to realise economic benefits

The TPP, IP and the Australasian healthcare industry – what’s at stake?

The Trans-Pacific Partnership (TPP) is a Free Trade Agreement (FTA) presently under negotiation by Australia, Brunei Darussalam, Chile, Canada, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States, and Vietnam. Its earliest origins date back to 2005 – and in December 2012, the fifteenth round of negotiations took place in Auckland, New Zealand. Recently, the

Progress toward New Zealand’s new Patents Act: End of year report card

As readers will know, New Zealand patent law has been in the throes of reform for the best part of a decade. The original exposure draft of the Patents Bill was released in 2004 – and since that time, we’ve penned a series of very similar articles, each entitled something along the lines of “Progress